• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Torrent Pharmaceuticals Ltd.
    16 Jul 2025
    3561.00
    0.83%
    Mid-Cap Stocks To Buy, Sell Or Hold: Torrent Pharma, One97 CommunicationsCheck Target Price
    Mid-Cap Stocks To Buy, Sell Or Hold: Torrent Pharma, One97 CommunicationsCheck Target Price
    NDTV Profit
    Mid-Cap Stocks To Buy, Sell Or Hold: Kush Bohra top picks for July 16 are Torrent Pharma and One97 Communications Ltd.
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 913 to 923 in Jun 2025 qtr.
    logo
    Sun Pharmaceutical Industries Ltd.
    15 Jul 2025
    Tariff Impact 52 week low
    1586.70
    -2.50%
    Sun Pharma gains on US launch of Leqselvi, analysts see strong upside
    Business Standard
    Sun Pharma rises 2.7% as it launches Leqselvi in US following settlement with Incyte, with analysts projecting $200-300 million revenue from the drug in 3-5 years
    Copy LinkShare onShare on Share on Share on
    Sun Pharmaceutical Industries Ltd. is trading at high day volume of 7.3M.
    Sun Pharma shares rise 2% on US launch of hair loss drug after settlement
    Business Standard | 15 Jul 2025 3 more
    Sun Pharma, Incyte settle Leqselvi lawsuit; launches alopecia drug in US
    Business Line | 14 Jul 2025
    Sun Pharma launches Leqselvi in US after patent settlement with Incyte Corp
    Business Standard | 14 Jul 2025
    Sun Pharma launches hair loss drug Leqselvi in US after patent settlement
    Business Standard | 14 Jul 2025
    logo
    Wockhardt Ltd.
    15 Jul 2025
    High Loss High Volume
    1336.50
    -9.46%
    Wockhardt To Focus On Drug Discovery And Biologics: Chairman Khorakiwala On Exiting US Generics Business
    Wockhardt To Focus On Drug Discovery And Biologics: Chairman Khorakiwala On Exiting US Generics Business
    NDTV Profit
    The leading pharma company's US generics business incurred a loss of $8 million in FY25.
    Copy LinkShare onShare on Share on Share on
    Wockhardt Ltd. has lost -11.24% in the last 1 Week
    logo
    AstraZeneca Pharma India Ltd.
    14 Jul 2025
    8811.50
    -2.39%
    AstraZeneca Pharma Gets CDSCO Nod For Import, Sale Of Bladder Cancer Drug
    AstraZeneca Pharma Gets CDSCO Nod For Import, Sale Of Bladder Cancer Drug
    NDTV Profit
    The receipt of this permission paves way for the marketing of Durvalumab Solution.
    Copy LinkShare onShare on Share on Share on
    AstraZeneca Pharma India Ltd. is trading above its 200 day SMA of 8188.7
    logo
    Anthem Biosciences Ltd.
    14 Jul 2025
    780.90
    -2.99%
    Anthem Biosciences IPO subscribed 73 pc on Day 1 of offer
    Business Standard
    The initial public offer of Anthem Biosciences Ltd got subscribed 73 per cent on the first day of share sale on Monday. The initial share sale received bids for 3,21,13,406 shares against 4,40,70,682 shares on offer, according to NSE data. Non-institutional Investors category garnered 1.55 times subscription, while the quota for Retail Individual Investors (RIIs) got subscribed 58 per cent. The portion for Qualified Institutional Buyers (QIBs) received 37 per cent subscription. Anthem Biosciences has raised Rs 1,016 crore from anchor investors. The Rs 3,395-crore IPO of the Bengaluru-based firm will close on July 16. The price band has been fixed at Rs 540-570 per share. Since the IPO is entirely an offer-for-sale (OFS), the company will not receive any funds from the issue, and the proceeds will go to the selling shareholders. Anthem is into innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization (CRDMO) with fully integrated operat
    Copy LinkShare onShare on Share on Share on
    Anthem Biosciences Ltd. is trading below all available SMAs
    logo
    Neuland Laboratories Ltd.
    14 Jul 2025
    13966.00
    -5.83%
    Neuland Laboratories shares jump 12% ahead of final dividend
    Neuland Laboratories shares jump 12% ahead of final dividend
    Economic Times
    Neuland Laboratories shares are experiencing a surge, trading 12% higher. This increase comes as investors anticipate a final dividend of Rs 12 per share. The record date for dividend eligibility is July 18, 2025. Technically, the stock shows a strong bullish trend. It trades above all analyzed Simple Moving Averages. The Relative Strength Index indicates neither oversold nor overbought conditions.
    Copy LinkShare onShare on Share on Share on
    Neuland Laboratories Ltd.'s price crossed below 30Day SMA today
    Mukul Agrawal portfolio pharmaceutical stock surges 10% in weak market
    Business Standard | 14 Jul 2025
    logo
    Wockhardt Ltd.
    14 Jul 2025
    High Loss High Volume
    1336.50
    -9.46%
    Wockhardt shares rise 2% after exiting US generics business
    Business Standard
    Wockhardt shares rose 2 per cent after it decided to exit the US generic pharmaceutical segment after incurring consistent losses
    Copy LinkShare onShare on Share on Share on
    Wockhardt Ltd. is trading at high volume of 2.3M with price loss of -9.46.
    Wockhardt To Exit US Generic Business; Focus On Antibiotics, Diabetes Care
    NDTV Profit | 13 Jul 2025
    logo
    Novartis India Ltd.
    14 Jul 2025
    875.70
    -1.35%
    Divi's Labs Shares Slide After Novartis' Entresto Loses Patent Lawsuit
    Divi's Labs Shares Slide After Novartis' Entresto Loses Patent Lawsuit
    NDTV Profit
    Divi's Labs makes active pharmaceutical ingredients for Entresto for Novartis, which contributes nearly 8% to Hyderabad-based drugmaker's revenue.
    Copy LinkShare onShare on Share on Share on
    Novartis India Ltd. is trading below all available SMAs
    logo
    Anthem Biosciences Ltd.
    14 Jul 2025
    780.90
    -2.99%
    Anthem Biosciences issue opens today in a price band of 540-570
    Business Line
    Mobilised 1,016-cr from anchor investors on Friday
    Copy LinkShare onShare on Share on Share on
    Anthem Biosciences Ltd. has gained 37.00% in the last 1 Year
    logo
    Sigachi Industries Ltd.
    14 Jul 2025
    38.09
    -2.31%
    Sigachi's lessons: A red line on safety for pharma manufacturing units
    Business Line
    Telangana and Andhra Pradesh attempt a course correction, but is it enough?
    Copy LinkShare onShare on Share on Share on
    Sigachi Industries Ltd. has lost -30.90% in the last 3 Months
    more
    loading
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • Jinkushal Industries
    • Chatterbox Technologies
    • Rukmani Devi Garg Agro Impex
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2025 Giskard Datatech Pvt Ltd (RA SEBI Reg No: INH000022507)